1-[4-(Trifluoromethyl)benzyl]-1H-pyrazol-5-amine, 1g

(S)-2,2,2-Trifluoro-1-(2-methoxyphenyl)ethanamine hydrochloride, 95%, 250mg

N,N-dimetilformamida, PEPTIPURE®, mínimo 99,8 %, para síntesis de péptidos, 2,5 l

2-[(3-nitro-2-pyridinyl)amino]ethanol, 95.0%, 5g

4-(2-methyl-1H-imidazol-1-yl)-2-butanone, 95.0%, 5g

Matraces aforados con tapón de vidrio, clase A Vidrio marrón, 50 ml, 12/21, 2 Pieza(s)

3-Chloro-5-isopropyl-1,2,4-oxadiazole, 95.0%, 1g

Methyl 3-amino-4-chloro-5-methoxybenzoate, 95+%, 100mg

Isothiazole-3-carbonitrile, 95.0%, 100mg

(S)-4-Ethyl-4-hydroxy-10-nitro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 95.0%, 250mg

2,2,2-Trifluoro-1-(4-(trifluoromethyl)phenyl)ethanol, 95%, 1g

Bismuth chloride, AR, 500g

3-Amino-5-boronobenzoic acid, 95.0%, 1g